Critical Care
Heart Failure
Mechanical Circulatory Support
Nursing & Allied Health
Canadian Association of Interventional Cardiology (CAIC)
Canadian Cardiovascular Critical Care Society (CANCARE)
Canadian Cardiac Transplant Network (CCTN)
Canadian Heart Failure Society (CHFS)
Andrew Caddell, MD, FRCPC
Cardiac Intensivist
CANCARE, CCTN
Dalhousie University
Yoan Lamarche, MD, MSc
Cardiac surgeon and Intensivist
Montreal Heart Institute
Montreal Heart Institute
Pierre-Emmanuel Noly, MD, PhD, FRCSC, FRQS (he/him/his)
Cardiac surgeon
Montreal Heart Institute
Université de Montréal
Maude Peretz-Larochelle, MD, FRCPC
CARDIOLOGIST
CCS, CANCARE
McGill University
Andrew Cao, MD
Cardiology Fellow
University of Toronto
Lior Bibas, MD FRCPC
Cardiologist
Hôpital Pierre Boucher
Université de Montréal
Warren Luksun, MD MSc [QIPS] FRCPC
Assistant Clinical Professor
CANCARE
University of Alberta
Caroline McGuinty, MD
Cardiologist
University of Ottawa Heart Institute
University of Ottawa
Dave Nagpal, MD
Cardiac Surgery / Critical Care Medicine
CCS, CSCS, CANCARE, CCTN
Western University
Maude Peretz-Larochelle, MD, FRCPC
CARDIOLOGIST
CCS, CANCARE
McGill University
Andrew Cao, MD
Cardiology Fellow
University of Toronto
Christopher Fordyce, MD, MHS, MSc
Cardiologist and CICU Director
Vancouver General Hospital
University of British Columbia
Adriana Luk, MD
Cardiologist
CANCARE
Toronto General Hospital, University Health Network and St. Michael's Hospital, Unity Health
Filio Billia, MD, PhD (she/her/hers)
Clinician-Scientist
University Health Network (UHN)
Andrew Cao, MD
Cardiology Fellow
University of Toronto
Christopher Fordyce, MD, MHS, MSc
Cardiologist and CICU Director
Vancouver General Hospital
University of British Columbia
Yoan Lamarche, MD, MSc
Cardiac surgeon and Intensivist
Montreal Heart Institute
Montreal Heart Institute
Sean Van Diepen, MD, FRCPC
Associate Professor
University of Alberta
University of Alberta
Workshop Description: Cardiogenic shock is a life-threatening condition where impaired heart function that leads to inadequate end-organ perfusion. In these cases, select patients may be supported using short term temporary mechanical circulatory support (t-MCS). Once patients are supported on MCS, decision making may include palliation due to progressive organ failure or following a complication of MCS therapy. In addition, there is uncertainty of best practices on when and how to test for readiness to wean from MCS therapies.
This symposium is designed for all health care provider who care for patients in cardiogenic shock, especially those in the critical care setting. We will present a clinical case followed by didactic sessions led by multidisciplinary faculty who will provide clinical pearls in initiating discussions for end-of-life care, as well as a summary of avoidance of MCS related complications. Given the lack of robust data regarding weaning of MCS strategies (ie. extracorporeal membrane oxygenation), we will have experts discuss timing and method of weaning in a debate format.